vietnamese crab exporter
Startup Battlefield – Where TechCrunch Introduces the Next Wave of Breakout Companies

Efferon

Efferon is a biotech company developing patented hemoadsorption technologies designed to remove endotoxins and inflammatory mediators.

Europe, Austria TechCrunch Disrupt 2026

Details

  • Industries

    Analytics Biotech AI/Machine Learning Manufacturing Deep tech

  • Operating Status

    Open

    Currently Raising
  • Website

    efferon.com

Founders

  • Dima Romashin

    Founder

  • Ivan Bessonov

    Founder

Highlights as of Aug 31, 2026

  • $5.5M

    Money Raised

Profile Updates

Have updates? Send them our way!

You know your company best! If there is information about your company that you’d like changed, please fill out the linked form to submit an update.

Contact TechCrunch

News About Efferon

No results.

Stay up-to-date on startup Battlefield

Sign up for our newsletter

Sign up to be notified on critical deadlines, updates, and more!

Sign Up Now